[New epidemiologic data show: conventional NSAIDs need individual benefit-risk evaluation].
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D016022:Case-Control Studies; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D003718:Denmark; D004008:Diclofenac / Q000009:adverse effects / Q000627:therapeutic use; D006306:Health Surveys; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000453:epidemiology; D016017:Odds Ratio; D012306:Risk; D018570:Risk Assessment
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D004008:Diclofenac